A previous analysis in this trial showed that among patients with severe, symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end point of death, stroke, or rehospitalization at 1 year was significantly lower with transcatheter aortic-valve replacement (TAVR) than with surgical aortic-valve replacement. Longer-term outcomes are unknown.
Each week, we choose a study that we believe will be of interest to the interventional cardiology community and discuss it at a virtual Journal Club with several of our faculty members.
Panelists
Presenter
